HLB Life Science Co., Ltd. wholesales and distributes pharmaceutical drugs. The Company through its subsidiaries provides targeted therapy, cell therapy, new drug development, medical devices production, and other related services. HLB Life Science also offers solar, geothermal, and other renewable energy engineering services.

Decision on Provision of Collateral for Others

Ex-Rights(ì ìì¦ì)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

HLB Life Science (067630 KS)

Decision on Provision of Collateral for Others

Ex-Rights(ì ìì¦ì)

Initial (Tentative) Issue Price of Rights Offering

Outcomes of Annual Meeting of Shareholders

Submission of Audit Report

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Decision on Provision of Collateral for Others

Ex-Rights(ì ìì¦ì)

Initial (Tentative) Issue Price of Rights Offering

Outcomes of Annual Meeting of Shareholders

Submission of Audit Report

Ex-Rights(ì ìì¦ì)